-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Whitehawk Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
- Whitehawk Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$18.9M, a 6.97% decline year-over-year.
- Whitehawk Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$67.5M, a 6.22% increase year-over-year.
- Whitehawk Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$67.5M, a 6.22% increase from 2023.
- Whitehawk Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$71.9M, a 14.8% decline from 2022.
- Whitehawk Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$62.7M, a 43.6% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)